Search Results - Jae‐Yong Chung

Population Pharmacokinetic Model of AST-001, L-Isomer of Serine, Combining Endogenous Production and Exogenous Administration in Healthy Subjects by Soyoung Lee, Soyoung Lee, Su-Kyeong Hwang, Su-Kyeong Hwang, Hee-Sook Nam, Jung-Sook Cho, Jae-Yong Chung, Jae-Yong Chung

Connect to this object online.

Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019 by Ki Young Huh, Eunwoo Kim, Soyoung Lee, Hyounggyoon Yoo, Seonghae Yoon, Kyung-Sang Yu, Jae-Yong Chung

Connect to this object online.

Estimation of the benefit from pre‐emptive genotyping based on the nationwide cohort data in South Korea by Ki Young Huh, Sejung Hwang, Joo Young Na, Kyung‐Sang Yu, In‐Jin Jang, Jae‐Yong Chung, Seonghae Yoon

Connect to this object online.

The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects by Sejung Hwang, Soyoung Lee, Eunwoo Kim, Inyoung Hwang, Joo‐Youn Cho, Jae‐Yong Chung, In‐Jin Jang, Jaeseong Oh

Connect to this object online.

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects by JungJin Oh, Eunsol Yang, In-Jin Jang, Hyejung Lee, Hokyun Yoo, Jae-Yong Chung, SeungHwan Lee, Jaeseong Oh

Connect to this object online.

Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects by Eunwoo Kim, Andrew Hyoungjin Kim, Yujin Lee, Sang Chun Ji, Joo‐Youn Cho, Kyung‐Sang Yu, Jae‐Yong Chung

Connect to this object online.

Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects by Hyounggyoon Yoo, Seonghae Yoon, In-Jin Jang, Kyung-Sang Yu, Joon Young Hyon, Jungi Hwang, Inyoung Hwang, Jung Sunwoo, Jae-Yong Chung

Connect to this object online.

Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males by Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo‐Youn Cho, In‐Jin Jang, Jae‐Yong Chung, Min‐Gul Kim, SeungHwan Lee

Connect to this object online.

Intravitreal long-term sustained ranibizumab delivery using injectable microgel-embedded hydrogel by Simin Lee, Jun Young Park, Hye Kyoung Hong, Joo Young Son, Byungwook Kim, Jae Yong Chung, Se Joon Woo, Ki Dong Park

Connect to this object online.

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib by Ki-Young Huh, Se-jung Hwang, Sang-Yeob Park, Hye-Jung Lim, Mir-yung Jin, Jae-seong Oh, Kyung-Sang Yu, Jae-Yong Chung

Connect to this object online.

Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects by Joo Young Na, Ki Young Huh, Kyung‐Sang Yu, Joon Young Hyon, Hye Cheong Koo, Jong Ho Lee, Ji Chang You, Jae‐Yong Chung

Connect to this object online.

Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects by Kyung‐Sang Yu, In‐Jin Jang, Hyeong‐Seok Lim, Jang Hee Hong, Min‐Gul Kim, Min Kyu Park, Doo‐Yeoun Cho, Min Soo Park, Jae Yong Chung, Jong‐Lyul Ghim, SeungHwan Lee, Seok Kyu Yoon, In Sun Kwon, Sang Joon Lee, Sung Hyun Kim, Yun Ju Bae, Jung Bin Cha, Daniel E. Furst, Edward Keystone, Jonathan Kay

Connect to this object online.